The Drosophila larval neuromuscular system is extensively used by researchers to study neuronal cell biology, and Drosophila glutamatergic motor neurons (MNs) have become a major model system. There are two main Types of glutamatergic MNs, Ib and Is, with different structural and physiological properties at synaptic level at the neuromuscular junction. To generate genetic tools to identify and manipulate MNs of each Type, we screened for GAL4 driver lines for this purpose. Here we describe GAL4 drivers specific for examples of neurons within each Type, Ib or Is. These drivers showed high expression levels and were expressed in only few MNs, making them amenable tools for specific studies of both axonal and synapse biology in identified Type I MNs.
INTRODUCTION
Drosophila research has contributed for decades to our understanding of both fundamental neuroscience (Bellen et al., 2010) , and neurological disorders (Ozdowski et al., 2015; Tan and Azzam, 2017; Xiong and Yu, 2018) . Much fruitfly neuroscience research is performed at the larval neuromuscular junction (NMJ), a well-characterized system with powerful genetic tools and accessible for physiology and cell biology (Menon et al., 2013) . The larval neuromuscular system has a relatively simple pattern that consists, in abdominal hemisegments from A2 to A7, of around 36 motor neurons (MNs) and 30 muscles (Landgraf and Thor, 2006) (Fig.  1) , with most muscles co-innervated by more than one Type of MN (Hoang and Chiba, 2001; Kim et al., 2009) . Depending on the NMJ bouton properties, different Types of MN have been described in Drosophila larvae. Type I MNs are excitatory and glutamatergic, and are subdivided into Ib (big) and Is (small). Type II and Type III MNs are neuromodulatory, being respectively octopaminergic and peptidergic. In addition, glutamatergic Type I MNs show different muscle innervation patterns: each Type Ib MN typically innervates one muscle, whereas each Type Is MN typically innervates several muscles (Hoang and Chiba, 2001; Kim et al., 2009) . The different Types of Type I MN also differ in their structural and physiological properties at synaptic level (Atwood and Klose, 2009 ). Type Ib synapses show shorter and less extensive branching, and support tonic (sustained) firing, whereas Type Is synapses show more extensive branching, and higher synaptic vesicle release efficacy per impulse, are more phasic (transient), and a higher proportion of their vesicle pool is readily releasable (Atwood et al., 1997; Atwood and Klose, 2009; Xing and Wu, 2018) .
To understand the properties of each Type of NMJ synapse, it is important to identify and manipulate different MN terminals independently. A common approach is labelling (typically using anti-Dlg) of the subsynaptic reticulum (SSR), comprising extensive infolding of the postsynaptic cell membrane, and whose amount differs among MN Types (Menon et al., 2013; Zito et al., 1999) . However, this approach has several limitations, especially when trying to distinguish different MNs with overlapping branches at the same NMJ: fewer channels available for fluorescence microscopy, especially in live imaging, and potential misidentification of bouton Types in genotypes or environmental conditions that affect SSR or bouton size. An approach to avoid all these limitations would be to use markers based on the genetic identity of the MN.
Using the GAL4/UAS system, is possible to express markers or functional proteins specifically in those cells expressing GAL4 (Brand and Perrimon, 1993) . While neuromodulatory MNs (Types II and III) are not as extensively studied as excitatory glutamatergic MNs (Ib and Is), specific GAL4 drivers have been reported for Type II (Stocker et al., 2018) and Type III (Park et al., 2003; Vömel and Wegener, 2007; Koon and Budnick, 2012) MNs. Several useful GAL4 drivers are expressed in Ib and Is MNs, but in some cases they are also expressed in neuromodulatory MNs (Koon and Budnick, 2012) , or in both Type Ib and Is MNs (Fujioka et al., 2003) . Other Type I-specific drivers are steroid-activated (Nicholson et al., 2008) . In addition, most of the mentioned lines are expressed in multiple MNs, and are therefore less amenable for studies on identifiable axons for which labeling of no more than 2 or 3 MNs would be desirable.
We therefore aimed to identify GAL4 drivers specific for small numbers of Type Ib or Is MNs. For this, we screened expression patterns in the larval abdominal nerve cord, in some of the neuronal GAL4 lines generated by the FlyLight project (https://www.janelia.org/projectteam/flylight), and identified two glutamatergic GAL4 lines, one specific for a single Type Ib MN, and the other specific for two Type Is MNs. We also identified other potential drivers for neuromodulatory MNs (Type II/III). We propose the two Type I-specific lines as tools of general interest for the Drosophila neuroscience community, improving the rigor and the accuracy of the study of both axonal and presynaptic biology.
RESULTS

Screening for potential drivers specific for glutamatergic MNs
The FlyLight project has generated around 7,000 transgenic Drosophila lines, in each of which expression of GAL4 is controlled by a different transcriptional enhancer that often drives expression in small subsets of neurons (Pfeiffer et al., 2008; Jennet et al., 2012) . To identify drivers specific for different classes of MN, we first reviewed images of the larval central nervous system, for 418 GAL4 lines listed as driving expression of the UAS-mCD8::GFP reporter in the abdominal ventral nerve cord (http://flweb.janelia.org/cgi-bin/flew.cgi). We prioritized candidates using several criteria: single or as few as possible cell bodies per neuromere in the VNC; axons visible in the nerves that innervate the body wall musculature (peripheral nerves); moderate or high GFP levels in axons.
We then analyzed selected candidate lines (Table 1) , using two different reporters to verify the GAL4 expression levels and distribution: a plasma membrane marker (UAS-CD4::GFP) to visualize the whole neuron, including cell body, axonal and presynaptic regions; and an endoplasmic reticulum (ER) marker (UAS-tdTom::Sec61β), previously described as continuously distributed throughout the whole neuron (Summerville et al., 2016; Wu et al., 2017) . Unless otherwise specified, we refer below to the plasma membrane marker. In addition, we checked the Type of NMJ produced by such cells. Type II presynaptic terminals are smaller and show longer branch length than Type I terminals, while Type III MNs show characteristic elongated or elliptical presynaptic terminals with an intermediate size between Type I and II (Jia et al., 1993) . Therefore, we used these properties to choose potential glutamatergic GAL4 lines (Supp. Fig. S1 ), and additionally used anti-Dlg labeling on a subset of lines (Supp Fig. S2 ) to assess the robustness of our identification criteria. We stopped screening once we found a line for each Type I MN (Ib and Is).
Using these criteria, we found two lines that appeared to express GAL4 in either Type Is or Type Ib MNs, GMR27E09 and GMR94G06 respectively, described in more detail below. In addition, we found several lines expressing in either Type II or Type III MNs, as well as three lines potentially expressing both in excitatory Type I MNs, and either Type II or Type III modulatory motor neurons (Supp. Table S1; Supp. Fig. S1, S2 ).
GMR27E09-GAL4 drives expression in two Type Is MNs per hemisegment
GMR27E09-GAL4 showed expression in two prominent cell bodies per hemineuromere ( Fig. 2 A, B) . These were located close to the midline, and projected their axons towards each peripheral nerve, one ipsilaterally and one contralaterally to the cell body ( Fig. 2 A-B ''). One of these cell bodies (projecting ipsilaterally) was located in the dorsal region of the VNC, and the other (projecting contralaterally) in the ventral region ( Fig. 2 B-B ''; Supp. Movies S1, S2). In the peripheral nerve, where both axons run parallel to each other, their paths were too close to distinguish by confocal microscopy in some regions (top panel on Fig. 2 C) , but we frequently found regions where both axons could be easily distinguished (bottom panel on Fig. 2 C) . Each axon innervated several internal muscles from a nerve branch found close to the intersegmental region. One of the MNs innervated proximal muscles (ventral and lateral), while the other MN innervated distal muscles (lateral and dorsal) ( Fig. 3 A, B) . Based on these data, we conclude these MNs are respectively part of the ISNb and ISN branches of the intersegmental nerve (Hoang and Chiba, 2001;  Fig.1) .
The short length of the presynaptic branches and the relatively big size of the presynaptic boutons, suggested that the two MNs expressing GMR27E09-GAL4 could be Type I or glutamatergic ( Fig. 3 A, B) . To test this possibility, and also distinguish between Type Ib and Is glutamatergic terminals, we double-labeled for GAL4-dependent reporter expression and anti-Dlg, whose postsynaptic distribution shows different sizes and levels between Ib and Is boutons (Menon et al., 2014) . The NMJ presynaptic terminals of both labeled axons showed detectable levels of Dlg, but did not include Type Ib boutons that showed the biggest and brightest anti-Dlg signals ( Fig. 4 A-C) . Since Only abdominal segments A2-A6 are represented, whose innervation and muscle pattern are identical. The ventral nerve cord (VNC) consists of segmentally repeated neuromeres that are bilaterally symmetrical across the midline (dotted line). Body wall muscles of each hemisegment are innervated by around 30 motor neurons (MNs), whose axons project together from one VNC neuromere, forming a peripheral nerve (black arrow). Anterior is to the top. B. Innervation of one of the abdominal hemisegments shown in A. In the VNC, the MN cell bodies project their axons via six main nerve branches: three intersegmental nerves, two segmental nerves, and a transverse nerve (runs along the segment border but has few MNs, so not represented). The muscles innervated by each nerve branch are represented in a lighter version of the color of each branch, and each muscle number is indicated. Dlg is absent in Type II and III NMJs (Menon et al. 2013) , we conclude that both MNs expressing GMR27E09-GAL4 are of Type Is.
At least three Type Is MNs have been described in larval abdominal hemisegments, each innervating multiple muscles from the ISN, SNa and SNb/d branches (Hoang and Chiba, 2001; Kim et al., 2009) . Our data suggest that GMR27E09-GAL4 line is expressed in two of these: ISNb/d-Is, which innervates ventral musculature contralaterally; and ISN-Is (also known as RP2), which innervates lateral and dorsal musculature ipsilaterally (Hoang and Chiba, 2001; Kim et al., 2009 ).
GMR94G06-GAL4 drives expression in a single Type Ib MN per hemisegment
Line GMR94G06-GAL4 was expressed in a single prominent cell body per hemineuromere in the VNC (Fig. 5 A) . This was located at the dorsal region of the VNC close to the midline, projected its axon ipsilaterally towards the peripheral nerve ( Fig. 5 A' , A''; Supp. Movies S3, S4). Therefore, each peripheral nerve contained just a single axon ( Fig. 5 B) . This axon innervated a dorsal muscle (muscle 1) from a nerve branch found close to the intersegmental region ( Fig. 6 A, B) . Therefore, we conclude that the axon follows the ISN branch of the intersegmental nerve ( Fig. 1) . No other innervation of the body wall muscles was detected ( Fig. 6 A, B) .
The large size of the presynaptic boutons, the short length of the NMJ branches, and innervation of a single muscle, suggest that the MN expressing GMR94G06-GAL4 is a Type Ib glutamatergic neuron. We confirmed this by showing that GMR94G06-GAL4 drove reporter expression only in presynaptic boutons with high levels of Dlg ( Fig. 7  A, B) . Based on the cell body position, the innervation of muscle 1, and the Type of NMJ (Ib), we conclude that GMR94G06-GAL4 is specifically expressed in MN1-Ib (also known as aCC) (Hoang and Chiba, 2001; Kim et al., 2009) .
Regulatory regions of GMR27E09-GAL4 and GMR94G06-GAL4 drivers
The MN-specific expression patterns are regulated by enhancers that are used to drive GAL4 expression (Pfeiffer et al., 2008; Jennet et al., 2012) . The driver GMR27E09-GAL4, expresses GAL4 using a fragment mainly from one of the introns of the Fmr1 gene, which is present in all recorded transcripts of Fmr1 (Fig. 8 A) . In GMR94G06-GAL4, the fragment controlling GAL4 expression comes from an intergenic region between two genes of the same family, dpr4 and dpr5 (Fig. 8 B) .
DISCUSSION
Importance of the identification of GMR27E09-GAL4 and GMR94G06-GAL4 drivers
We have identified and characterized two GAL4 lines specific for different Types of Drosophila larval glutamatergic MNs. GMR27E09-GAL4 is expressed in MN ISNb/d-Is and MN ISN-Is (RP2), while GMR94G06-GAL4 is expressed in MN1-Ib (aCC). Interestingly, one of the most widely used drivers to analyze specific glutamatergic NMJs is the line RN2-GAL4 (or eve-GAL4), which is expressed in aCC and RP2 (Fujioka et al., 2003; Landgraf et al., 2003) . Therefore, the drivers identified here allow to study these same well characterized MNs, aCC and RP2, but separately from each other. The alternative approach of clonal labeling of individual neurons (Roy et al., 2007) requires complex genetics and is not consistent between samples. Here we identified classical GAL4 drivers expressed only in Type Is or Type Ib MNs, which are respectively expressed in two MNs or a single MN per hemisegment, allowing simultaneous axonal and NMJ studies in both fixed or in vivo experiments.
MN identity and regulation of GMR27E09-GAL4 and GMR94G06-GAL4 drivers
The gene expression patterns that govern identity of each MN including its pathfinding and synaptic partners (Landgraf and Thor, 2006) , are ultimately regulated by enhancers. The GMR27E09-GAL4 and GMR94G06-GAL4 drivers express GAL4 under the control of genomic Fmr1 encodes an RNA-binding protein, which acts as a neural growth brake regulating RNA trafficking, translation and neuronal excitability, and whose downregulation contributes to Fragile X syndrome in humans (Banerjee et al., 2010) . Although Fmr1 is widely expressed (Wan et al., 2000) and its function is generally required in Drosophila larvae MNs (Zhang et al., 2001) , the regulatory sequence controlling GMR27E09-GAL4 (Fig. 8 A) drives much more restricted expression than that of Fmr1.
The Dpr family comprises 21 different genes, which encode neuronal surface receptors required for synapse organization. Several Dpr genes are expressed in different subsets of neurons in the Drosophila larval VNC, acting as synaptic labels and thus allowing specific synaptic connectivity (Carrillo et al., 2015) . Although there is no information available about the expression patterns of the Dpr4 and Dpr5 genes located close to the regulatory region in GMR94G06-GAL4 (Fig. 8 B) , it is not unexpected that this regulatory region controls expression in a specific MN.
Future perspectives
GMR27E09-GAL4 and GMR94G06-GAL4 are specific drivers for two Type Is MNs and a single Type Ib MN, respectively, per Drosophila larvae hemisegment, thus allowing the specific labeling of these Types of MN. This will allow labeling, live imaging, and manipulation of these specific classes of MN, to better understand the biology of the NMJ and its physiologically diverse Types of synapse.
EXPERIMENTAL PROCEDURES
Drosophila genetics
All Drosophila stocks were obtained from the Bloomington Drosophila Stock Center, and are listed in Table 1 . (Pfeiffer et al., 2008; Jennet et al., 2012) ; 2 (Han and Jan, 2011); 3 (Summerville et al., 2016) . 
Histology and immunomicroscopy
Third instar larvae were dissected in chilled Ca 2+ -free HL3 solution (Stewart et al., 1994) , and fixed for 15 min in PBS with 4% formaldehyde. For immunostaining, the dissected preparations were permeabilized in PBS containing 0.1% Triton X-100 (PBT) at room temperature for 1 h. Factin was stained by incubating dissected samples for 30 minutes at room temperature with Texas Red X-Phalloidin 1:400 (T7471, Thermo Fisher Scientific). For immunostaining, after permeabilization, samples were blocked in PBT with 4% bovine serum albumin for 30 min at room temperature, incubated with primary antibodies overnight at 4ºC, and finally incubated with secondary antibodies for 2 h at room temperature. Primary antibody was: mouse anti-Dlg 1:100 (4F3, Developmental Studies Hybridoma Bank; Parnas et al., 2001) , and secondary antibody was: goat anti-mouse conjugated to Alexa-647 (A21247, Thermo Fisher Scientific). Processed preparations were mounted in Vectashield (Vector Laboratories), and images were collected using EZ-C1 acquisition software (Nikon) on a Nikon Eclipse C1si confocal microscope (Nikon Instruments, UK). Images were captured using a 40x/1.3NA oil objective.
Image analysis and Figure preparation
All the microscopy images shown are maximum intensity projections derived from confocal stacks. In the VNC, labeled axonal projections were tracked through sections from cell bodies towards the peripheral nerve, and from the peripheral nerve to the NMJ and muscles. In Fig. 4 and 7, outline of muscles in specific NMJs was identified by using brightfield microscopy. Similarly, the innervation pattern showed in Supp. Table  S1 . was identified by using bright-field microscopy. All images were opened, analyzed and processed using ImageJ FIJI (https://fiji.sc) (Schindelin et al., 2012) . Figures were made using Adobe Illustrator.
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